{"nct_id":"NCT01865747","title":"A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2013-06","start_date_type":null,"primary_completion_date":"2015-05-22","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["EXEL"]}